SCHEMBL14701629

SCHEMBL14701629

O=Cc1cn(-c2ccc(F)cc2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
KCNJ1 P48048 1/20 0.35
POLB P06746 1/20 0.35
HCAR1 Q9BXC0 1/20 0.34
MGLL Q99685 1/20 0.33
PTGS2 P35354 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
NLRP3 Q96P20 1/20 0.33
P2RX7 Q99572 1/20 0.33
CYP3A4 P08684 2/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
TERT O14746 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29691089 0.82 NPC1 (0.50) ALDH1A1KCNJ1POLBMGLLPTGS2
SCHEMBL16043335 0.82 MAP4K4 (0.46) KCNJ1MGLLPTGS2NPC1RAB9A
SCHEMBL11765378 0.82 CYP2A6 (0.42) ALDH1A1KCNJ1HCAR1MGLLNPC1
SCHEMBL7563959 0.81 P2RX7 (0.50) ALDH1A1PTGS2NPC1RAB9ANLRP3
SCHEMBL22158979 0.81 TDP1 (0.41) KCNJ1PSEN1PSEN2APH1BNCSTN
SCHEMBL23013807 0.78 OTUD7B (0.40) POLBKDM4ECYP11B2
SCHEMBL16055887 0.77 PSEN1 (0.35) ALDH1A1NPC1RAB9APSEN1PSEN2
SCHEMBL1698791 0.77 ALDH1A1 (0.43) ALDH1A1POLBPTGS2TERTCYP1A2
SCHEMBL17632468 0.76 LMNA (0.38) ALDH1A1HCAR1NPC1RAB9ANLRP3
SCHEMBL12443628 0.75 NPC1 (0.37) ALDH1A1HCAR1MGLLNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9284350-B2 IAP BIR domain binding compounds PHARMASCIENCE INC. (CA) 2016-03-15 US disclosed
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS PHARMASCIENCE INC. (CA) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS BIRC5, BIRC2, BIRC3 ALDH1A1 4122/4885KCNJ1 4073/4885POLB 1800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.